Literature DB >> 3149883

Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

G V Doern1, R N Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3149883      PMCID： PMC176011          DOI： 10.1128/AAC.32.12.1747

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  57 in total

1.  Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984.

Authors:  R J Rice; J W Biddle; Y A JeanLouis; W E DeWitt; J H Blount; S A Morse
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

2.  Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.

Authors:  E E Stobberingh; H J van Eck; A W Houben; C P van Boven
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors:  R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Identification and antimicrobial susceptibility testing of Branhamella catarrhalis in United States laboratories, 1983-1985.

Authors:  R N Jones; H M Sommers
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 5.  Branhamella catarrhalis--an emerging human pathogen.

Authors:  G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

6.  In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.

Authors:  K G Sweeney; A Verghese; C A Needham
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.

Authors:  G V Doern; K C Chapin
Journal:  Diagn Microbiol Infect Dis       Date:  1986-01       Impact factor: 2.803

8.  An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b.

Authors:  A A Medeiros; R Levesque; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

9.  Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands.

Authors:  B I Davies; F P Maesen
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston; T Tubert; J S Redding; L A Maher
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191
View more
  19 in total

Review 1.  In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations.

Authors:  G V Doern
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.

Authors:  E Bingen; F Bourgeois; H Chardon; C Doit; N Lambert-Zechovsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

3.  Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.

Authors:  L D Tremblay; J L'Ecuyer; P Provencher; M G Bergeron
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

4.  Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.

Authors:  N C James; K H Donn; J J Collins; I M Davis; T L Lloyd; R W Hart; J R Powell
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 5.  The use of oral antibiotics in daily clinical practice.

Authors:  A Verghese
Journal:  Drugs       Date:  1991       Impact factor: 9.546

6.  Problems with current recommendations for susceptibility testing of Haemophilus influenzae.

Authors:  P M Mendelman; E A Wiley; T L Stull; C Clausen; D O Chaffin; O Onay
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

7.  Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.

Authors:  B A Brown; R J Wallace; C W Flanagan; R W Wilson; J I Luman; S D Redditt
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis.

Authors:  L V Möller; L van Alphen; H Grasselier; J Dankert
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

Review 9.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

Review 10.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.

Authors:  T Fekete
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.